PILL — Direxion Daily Pharmaceutical & Medical Bull 3X Shares
Data updated: 2026-06-29
PILL — Direxion Daily Pharmaceutical & Medical Bull 3X Shares data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. Leveraged · $12.89M AUM · 0.97% expense ratio · 118.0% 1-yr return. From SEC regulatory filings.
PILL Fund Overview
PILL — Direxion Daily Pharmaceutical & Medical Bull 3X Shares is a US ETF managed by Direxion Shares ETF Trust, categorised as Leveraged. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Direxion Shares ETF Trust
- Category: Leveraged
- Assets under management: $12.89M
- 1-year return: 118.0%
- Ticker: PILL
- SEC CIK: 0001424958
- SEC series ID: S000050532
- Share class ID: C000159441
PILL Holdings
Top 10 holdings of Direxion Daily Pharmaceutical & Medical Bull 3X Shares by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Goldman Financial | 18.99% |
| Dreyfus Government Cash Manage | 3.75% |
| Organon & Company | 2.77% |
| Corcept Therapeutics, Inc. | 1.85% |
| Enliven Therapeutics, Inc. | 1.80% |
| Axsome Therapeutics, Inc. | 1.74% |
| Omeros Corp. | 1.64% |
| Perrigo Company PLC | 1.62% |
| Definium Therapeutics, Inc. | 1.57% |
| Nektar Therapeutics | 1.55% |
PILL Portfolio Allocation
Asset-class allocation of Direxion Daily Pharmaceutical & Medical Bull 3X Shares by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 74.5% |
| Cash & Equivalents | 22.7% |
| Derivatives | 6.2% |
PILL Performance
Total returns for PILL (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 0.2% |
| 1 year | 118.0% |
| 3 years (annualised) | 12.0% |
| 5 years (annualised) | -9.0% |
PILL Risk Information
Risk metrics for PILL, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 62.9%
PILL Costs and Fees
PILL costs about $97 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.97%
- Gross expense ratio: 1.15%
- Portfolio turnover: 67%
- Brokerage commissions: 30.95 bps of average net assets (SEC N-CEN)
PILL Cashflows
Over the 12 months to 2026-04, Direxion Daily Pharmaceutical & Medical Bull 3X Shares had net outflows of $9.39M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | −$556.84K |
| 2026-03 | −$3.99M |
| 2026-02 | −$1.29M |
| 2026-01 | $1.24M |
| 2025-12 | $13.54K |
| 2025-11 | $1.01M |
PILL Debt Constituents
No individual debt constituents are reported in Direxion Daily Pharmaceutical & Medical Bull 3X Shares's latest SEC N-PORT filing.
PILL Prospectus and SEC Filings
Official Direxion Daily Pharmaceutical & Medical Bull 3X Shares filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other Leveraged funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.